INTRODUCTION
============

In clinical studies, patients are often classified into low- and high-risk groups based on prognostic factors. For example, serum creatinine level might be an important prognostic factor for rejection after renal transplantation. If a patient has no acute rejection and a low serum creatinine level for six months after transplantation, administered steroids are often withdrawn. A cutpoint value of 2.0 (unit: mg/dL) is commonly used as a threshold for serum creatinine to make this clinical decision. In this case, patients with a serum creatinine level less than or equal to 2.0 could be classified into the low-risk group and those with level greater than 2.0 into the high-risk group.

When an event of interest is survival time, one of the most popular procedures is to minimize the *p* value associated with the log-rank statistic. A considerable amount of work has dealt with censored outcomes based on a maximally selected linear rank statistic.[@B1][@B2][@B3][@B4][@B5] These methods can be applied to situations with only one type of event; however, patients may experience several types of events during follow up, which may compel an analysis with the competing risks (CR) framework. Woo, et al.[@B6] proposed a method to determine a cutpoint value of a prognostic factor on censored outcomes in the presence of CR. They also proposed a maximally selected Gray\'s test statistic[@B7][@B8] for testing whether there is an association between the event of interest and the prognostic factor, and approximated the asymptotic distribution using the arguments.[@B4][@B9] However, it turned out that the test procedure was conservative under moderate to heavy censoring.[@B6] In this article, we propose test statistics to circumvent these shortcomings.

This article is organized in the following manner. We first propose a cutpoint estimator for a prognostic factor that produces the largest difference in the event of interest between individuals in low- and high-risk groups under a CR framework. Two different procedures are proposed to test whether an association between the event of interest and the prognostic factor is statistically significant at the estimated cutpoint of the prognostic factor. Simulations are conducted to investigate the performance of the cutpoint estimator in terms of bias and precision and the efficiency of the proposed tests in terms of power. We also analyze lung cancer data collected from Samsung Seoul Hospital in Korea to illustrate our proposed methodologies. Finally, brief discussions are provided.

MATERIALS AND METHODS
=====================

Materials
---------

From September 1, 1991 to December 31, 2005, 758 lung cancer patients underwent tumor removal surgery at Samsung Medical Center in Korea. This study was conducted over more than 16 years and the observed follow-up times ranged from 0.3 to 195 months. In this study, relapse after the surgical process corresponds to the event of interest, and death corresponds to a CR. Among the patients, 580 relapsed (76.5%), 65 died without relapse (8.6%), and 113 were censored (14.9%). The prognostic factor was tumor size (unit: cm) at surgery, which ranged from 0 to 19. A box plot of tumor size with the five numbers is displayed in [Fig. 1](#F1){ref-type="fig"}. Moreover, summary statistics of time to event occurrence and tumor size are presented in [Table 1](#T1){ref-type="table"} depending on the event type, such as censoring, relapse, or death.

Models and notations
--------------------

Let *X*, *Y*, and *C* be the time of the event of interest, the time of CR, and a censoring time, respectively. Let δ=1 if the event of interest occurred, 2 if the CR occurred, and 0 if censored. Let

be observed data, where *Z~i~* is a continuous prognostic factor. Suppose that

are the ordered distinct times at which the event of interest occurs and that

is the set of labels of subjects that fail at *t~(u)~*, *u*=1, 2, ..., *m*. In addition, suppose that

$$C\left( t_{(u)} \right) = \left\{ u_{1}^{\prime},u_{2}^{\prime},\ldots,u_{c_{u}}^{\prime} \right\}$$

is the set of labels of subjects censored or failed due to CR in the interval \[*t~(u)~*, *t~(u+1)~*), *u*=0, 1, ..., *m*.

For a fixed value of µ, set *g*=1 if Z≤µ and 1 otherwise. Let *d~g,u~(µ)* and *r~g,u~(µ)* denote the number of subjects to whom the event of interest occurs at *t~(u)~* and the number of subjects who are at risk up to time *t~(u)~* in group *g*, respectively. Let *r~u~*=*r~1,u~(µ)*+*r~2,u~(µ)*. Let *F~g,µ~(t)* be the cumulative incidence function (CIF) for the event of interest and *S~g,µ~(t)* be the survival function of being free from any event at *t* in group *g*, respectively. The estimated CIF^8^ of *F~g,µ~(t)* is given by

$${\hat{F}}_{g,µ}\left( t \right) = {\sum\limits_{u:t_{(u)} \leq t}{\hat{S}}_{g,µ}}\left( t_{({u - 1})} \right)\frac{d_{g,u{(µ)}}}{r_{g,u}\left( µ \right)},$$

where *Ŝ~g,µ~(t)* is the Kaplan-Meier estimator for *S~g,µ~(t)*.[@B10] Define

$$w_{g,u}\left( µ \right) = \frac{1 - {\hat{F}}_{g,µ}\left( t_{({u - 1})} \right)}{{\hat{S}}_{g,µ}\left( t_{({u - 1})} \right)}$$

as a correction factor at *t~(u)~* in group *g*. Let *r̃~g,u~(µ)*=*w~g,u~(µ)r~g,u~(µ)* and *r̃~u~(µ)*=*r̃~1,u~(µ)*+*r̃~2,u~(µ)*. Define the score for a subject in *D(t~(u)~)* at *t~(u)~* as

$$a_{l,u}\left( µ \right) = 1 - {\sum\limits_{j = 1}^{u}{\left\{ {\sum\limits_{g = 1}^{2}{I_{l,g}\left\{ µ \right\} w_{g,j}\left\{ µ \right\}}} \right\}\frac{d_{j}}{{\overset{\sim}{r}}_{j}\left( µ \right)}\text{for}\quad l}} \in D\left( t_{(u)} \right),$$

where *I~i,g~(µ)*=1 if subject *i* is a member of group *g* and 0 otherwise. Also, define the score for a subject in *C(t~(u)~)* at *t~(u)~* as

$$A_{l^{\prime},u}\left( µ \right) = \left\{ \begin{matrix}
{0,\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad\quad u = 0;\quad\quad\quad} \\
{- {\sum\limits_{j = 1}^{u}\left\{ {\sum\limits_{g = 1}^{2}{I_{l^{\prime},g}\left\{ µ \right\} w_{g,j}\left\{ µ \right\}}} \right\}}\frac{d_{j}}{{\overset{\sim}{r}}_{j}\left\{ µ \right.},u = 1,2,\ldots,m} \\
\end{matrix} \right.$$

for *l′*∈*C(t~(u)~)*. We call these scores the Gray-statistic-type scores and denote ā~µ~ by their average score.

Maximally selected rank statistics
----------------------------------

The testing problem of interest is the independence of *X* and *Z*, setting up the null hypothesis as

for all *t*∈(0,∞) and all cutpoints µ in the prognostic factor *Z*. It was showed that, for a fixed value of µ, the Gray\'s test statistic[@B7][@B8] for testing the hypothesis of (1) is equivalent to a linear rank statistic,[@B6]

$$L_{µ} = {\sum\limits_{u = 1}^{m}{{\sum\limits_{l \in D(t_{(u)})}{I_{l,1}\left( µ \right)a_{l,u}\left( µ \right)}} + {\sum\limits_{u = 0}^{m}{\sum\limits_{l\prime \in C(t_{(u)})}{I_{l^{\prime},1}\left( µ \right)A_{l^{\prime},u}\left( µ \right).}}}}}$$

Let $H_{z}\left( µ \right) = n^{- 1}{\sum_{i = 1}^{n}{I\left\{ {Z_{i} \leq µ} \right\}}}$ denote the empirical distribution function of the prognostic factor *Z*. Let *m~µ~*=*nH~Z~(µ)* and *n~µ~*=*n−m~µ~*. Following the arguments,[@B1][@B2][@B5] under *H~0~*, given the scores, the expectation and the variance of *L~µ~* are

$$E\left( L_{µ} \middle| Z \right) = \frac{m_{u}}{n}{\sum\limits_{u = 1}^{m}{\left\{ {{\sum\limits_{l \in D(t_{\{ u\}})}{a_{l,u}\left( µ \right)}} + {\sum\limits_{l\prime \in C(t_{\{ u\}})}{A_{l^{\prime},u}\left( µ \right)}}} \right\} = m_{µ}{\overset{-}{a}}_{µ}}}$$

and

$$v\left( L_{µ} \middle| Z \right) = \frac{m_{µ}n_{µ}}{n\left( {n - 1} \right)}\left\{ {\sum\limits_{u = 1}^{m}{\sum\limits_{l \in D(t_{\{ u\}})}{\left\{ {a_{l,u}\left\{ µ \right\} - {\overset{-}{a}}_{µ}} \right\}^{2} + {\sum\limits_{u = 0}^{m}{\sum\limits_{l\prime \in C{\{ t_{\{ u\}}\}}}\left\{ {A_{l^{\prime},u}\left\{ µ \right\} - {\overset{-}{a}}_{µ}} \right\}^{2}}}}}} \right\}.$$

Then, the standardized statistic of *L~µ~* is defined as

$$T_{µ} = \frac{L_{µ} - E\left( L_{µ} \middle| Z \right)}{\sqrt{V\left( L_{µ} \middle| Z \right)}}.$$

Under *H~0~*, *T~µ~* is asymptotically normally distributed using the arguments.[@B11]

Let ξ(ε,*Z*)=min {µ:*H~z~(µ)*≥ε}. We restrict the possible cutpoints to an interval \[ξ(ε~1~,*Z*),ξ(ε~2~,*Z*)\] with 0\<ε*~1~*\<ε*~2~*\<1. In the same fashion,[@B1][@B2][@B5] we define a cutpoint estimator µ̂(ε*~1~*,ε*~2~*) as the value of µ that yields the maximum of the absolute of *T~µ~*, i.e.,

$$\hat{µ}\left( {\varepsilon_{1},\varepsilon_{2}} \right) = \text{min}\left\{ {\text{argmax}_{µ \in {\lbrack{\xi(\varepsilon_{1},Z),\xi(\varepsilon_{2},Z)}\rbrack}}\left| T_{µ} \right|} \right\}.$$

In addition, we define a maximally selected rank statistic as

$$Q\left( {\varepsilon_{1},\varepsilon_{2}} \right) = \binom{\text{max}}{µ \in \left\lbrack {\xi\left\lbrack {\varepsilon_{1},Z} \right\rbrack,\xi\left\lbrack {\varepsilon_{2},Z} \right\rbrack} \right\rbrack}\left| T_{µ} \right|.$$

From the arguments,[@B1][@B2][@B5] the asymptotic distribution of *Q*(ε*~1~*,ε*~2~*) is equivalent to the distribution of the supremum of a standardized Brownian bridge. Thus, the approximation[@B12] under *H~0~* gives

$$Pr\left( {Q\left( {\varepsilon_{1},\varepsilon_{2}} \right) \geq q} \right) \approx \frac{4\phi\left( q \right)}{q} + \phi\left( q \right)\left( {q - \frac{1}{q}} \right)\text{log}\left( \frac{\varepsilon_{2}\left( {1 - \varepsilon_{1}} \right)}{\left( {1 - \varepsilon_{2}} \right)\varepsilon_{1}} \right),q \in \left( {0,\infty} \right),$$

where ϕ(·) denotes a standard normal density.

However, as shown in [Table 2](#T2){ref-type="table"}, the testing procedure based on the approximation of (2) seems to be conservative. Instead, we propose a permutation test based on *B* permuted samples by permutingthe observed values of the prognostic factor *Z*. To be specific, denote *Q~b~*(ε*~1~*,ε*~2~*) by the *b^th^*(*b*=1, 2, ..., *B*) permuted value of *Q*(ε*~1~*,ε*~2~*) based on

where *P~n~* is a set of all permutations of integers 1 to *n*. Suppose that the value of *Q*(ε*~1~*,ε*~2~*) based on the observed data set {***D**~i~*:*i*=1, 2, ..., *n*} is *q~0~*. Then, the probability in the left-hand side of (2) is empirically determined by

$$\frac{1}{B}{\sum\limits_{b = 1}^{B}{I\left\{ {Q_{b}\left\{ {\varepsilon_{1},\varepsilon_{2}} \right\} \geq q_{0}} \right\}}},$$

called the empirical *p* value corresponding to the observed value of *q~0~*.

RESULTS
=======

Simulation studies
------------------

We performed simulations to investigate the finite-sample performance of the proposed methods in terms of bias and standard deviation (SD) of the cutpoint estimator and the empirical power of the maximally selected test statistics. We generated a time to the event of interest (*X*) and time to a CR (*Y*) using Gumbel\'s bivariate exponential distribution[@B13][@B14] with degree of dependency α set as 0 and 0.3. We generated a non-informative censoring time C from an exponential distribution with a hazard rate of λ(\>0), which was determined to satisfy *P*(*C*\<*X*⋀*Y*)=*p*, where *p* denotes the censoring fraction. We set *p*=0 and 0.3. We also generated the prognostic factor *Z* from a uniform distribution *U*(0,1) and set the true cutpoint value µ as 0.5. We set ε*~1~*=0.1 and ε*~2~*=0.9. The effect size θ=exp(β) was the relative risk between the two groups of patients, where *Z* was greater than or less than or equal to µ. We set β as 0, 1, 1.5, 2, and 3: β=0 corresponded to the null hypothesis and β=1, 1.5, 2, and 3 corresponded to the alternative hypotheses. We considered four combinations of α and *p*: (α,*p*)=(0,0), (0,0.3), (0.3,0), (0.3,0.3). We performed 500 replications for each configuration of α and *p* with sample sizes of 50, 100, and 200. We also permuted each sample 250 times to obtain the empirical null distribution of *Q*(ε*~1~*,ε*~2~*). [Fig. 2](#F2){ref-type="fig"} depicts the empirical *p* values of the proposed test *Q*(ε*~1~*,ε*~2~*) based on a simulated sample against the number *b* of permutation times for each combination of α and *p* under *H~0~*:β=0. As shown in [Fig. 2](#F2){ref-type="fig"}, the number *B*=250 of permutation times was chosen as acceptable regardless of the sample size and the combinations of α and *p*. See the work[@B6] for details of the data generation procedures. [Fig. 3](#F3){ref-type="fig"} depicts the empirical distribution function of μ̂ based on 2000 replications, with the sample size of 100 for each combination of α and *p* when β=0, 1, 1.5, 2, and 3. As expected, regardless of the combinations of α and *p*, the distribution of μ̂ is centered around the true cutpoint value 0.5 of µ as β increases from 0 to 3.

[Table 2](#T2){ref-type="table"} displays the proportion of CR, the bias (Bias) and SD of the cutpoint estimator μ̂, and the approximated (A.Pow) and permutation-based (P.Pow) power of the proposed test statistic *Q*(ε*~1~*,ε*~2~*). These are based on 500 replications and 250 permutations for each combination of α and *p* when *n*=50, 100, and 200. As expected, as β increases, the SD of μ̂ decreases gradually, and both A.Pow and P.Pow converge to 1 regardless of the combination of α and *p* and sample size *n*. For a fixed value of β, as *n* increases, both Bias and the SD of μ̂ decrease; also, both A.Pow and P.Pow increase for any combination of α and *p*. The permutation-based test (P.Pow), included in the interval (0.031,0.069), satisfies a significance level of 0.05 for most cases, while the approximated test (A.Pow) is very conservative. Furthermore, P.Pow is larger than A.Pow regardless of the combination of α and *p* and sample size *n*.

Real data analysis
------------------

Based on the proposed test statistic *Q*(ε*~1~*,ε*~2~*), we split the patients into two groups for relapse, a high-risk group and a low-risk group, to apply different treatments to each group. We set ε*~1~* and ε*~2~* as 0.1 and 0.9, respectively. As shown in [Table 3](#T3){ref-type="table"}, at the first split of 758 patients, the criterion was tumor size of 1.8, and the CIFs for relapse of the two groups were different (*p* value\<0.001). We further investigated whether the patients within each subgroup were homogeneous in experiencing relapse after surgery in terms of *Q*(ε*~1~*,ε*~2~*). The group with a tumor size less than or equal to 1.8 was statistically homogeneous (*p* value=0.096), while the group having tumor size greater than 1.8 was not homogeneous (*p* value\<0.001). In the same way, we applied a binary split of only the group with a tumor size greater than 1.8. The next split criterion was a tumor size of 3, and only the group with a tumor size greater than 3 was not homogeneous (*p* value=0.020). The third split was 6.5, and both groups, tumor size less than or equal to 6.5 or greater than 6.5, were homogeneous with *p* values of 0.530 and 0.957, respectively. The top left panel of [Fig. 4](#F4){ref-type="fig"} depicts the standardized linear rank statistics *T~µ~* against tumor size (solid line). The 1st, 10th, 90th, and 99th quantile points of tumor size along with the estimated cutpoint μ̂ of 1.8 are indicated on the axis of tumor size with symbols of black square, black circle, black triangle, and black diamond, respectively. In the top right panel, the CIFs of two groups, tumor size greater than 1.8 (dashed line) and less than or equal to 1.8 (solid line), are displayed. In the same way, plots in the second and third rows of [Fig. 4](#F4){ref-type="fig"} are respectively drawn with the subgroups of 594 patients having tumor size greater than 1.8 and of 334 patients having tumor size greater than 3. In summary, we could classify the patients with tumor size less than or equal to 1.8 into a low-risk group, while the patients included in a high-risk group (i.e., having tumor size more than 1.8) could be further classified into three subgroups, lowest, moderate, and highest high-risk groups, depending on tumor sizes at surgery of 1.8 to 3, 3 to 6.5, and over 6.5, respectively.

DISCUSSION
==========

Based on a maximally selected linear rank statistic, we estimated a cutpoint for a continuous prognostic factor that produced the largest difference in the event of interest between individuals in high- and low-risk groups in a CR framework. Approximation-based and permutation-based tests were proposed to test an association between the event of interest and the prognostic factor at the estimated cutpoint of the prognostic factor. The permutation-based test procedure was proposed to overcome the conservativeness of the test based on the approximation of the asymptotic distribution of the maximally selected rank statistic. Simulation results showed that the SD of the estimated cutpoint decreased as the association between the event of interest and the prognostic factor became stronger, regardless of the combination of degree of dependency between two CR and a censoring fraction. Moreover, most cases showed that the permutation-based test satisfied a significance level of 0.05, while the approximated test was very conservative: the powers of the former were larger than those of the latter. We applied our method to data collected from a study on lung cancer patients. We used tumor size prior to surgery for classifying the patients into two groups (low and high risks for relapse). Based on the results, the optimal cutpoint value of tumor size (unit: cm) was 1.8 with ε*~1~*=0.1 and ε*~2~*=0.9. In addition, the times to relapse between subgroups of patients with tumor size less than or equal to 1.8 (low risk of relapse) and more than 1.8 (high risk of relapse) were significantly different (*p* value \<0.001). The patients with tumor size over 1.8 could also be further classified into three subgroups: those with tumor size of 1.8 to 3 (lowest high risk of relapse), 3 to 6.5 (moderate high risk of relapse), and over 6.5 (highest high risk of relapse).

Following the argument,[@B7] we also defined the risk set of the *i^th^* subject at time *t* as

$$Y_{i}^{G}\left( t \right) = \frac{1 - F\left( t \right)}{S\left( t \right)}I\left( t \leq T_{i} \right)$$

(called an adjusted method). However, since the process $Y_{i}^{G}\left( t \right)$ excludes the contribution of the subjects who are censored by an earlier occurrence of the competing risks than an event of interest, as suggested by a referee, we could replace this process by the following process,[@B15]

$$Y_{i}^{F\& G}\left( t \right) = I\left( {t \leq T_{i}} \right) + I\left( {X_{i}\bigwedge Y_{i} \leq C_{i}} \right)\frac{\hat{G}\left( {t -} \right)}{\hat{G}\left( {\left( {X_{i}\bigwedge Y_{i}} \right) -} \right)}I\left( {X_{i}\bigwedge Y_{i} < t,\delta_{i} = 2} \right).$$

Here, *Ĝ(t)* is the Kaplan-Meier estimator of the censoring survival function *G(t)*=*P*(*C*\>*t*).[@B10] It is called *Ĝ*(*t*−)/*Ĝ*((*X~i~*⋀*Y~i~*)−) in the second term of (3) the inverse probability of censoring weighing (called an IPCW method). In the future, both the adjusted and IPCW methods will be compared with extensive simulations. Furthermore, our proposed approach can be extended to cases of CR with multiple prognostic factors. As a matter of fact, for the survival data with *K*(≥2) prognostic factors, Lausen, et al.[@B5] proposed an adjusted minimal *p*-value approach. However, under the CR frameworks, it may not be straightforward to derive analytically the asymptotic distribution of the minimum of *Q*(*k*;ε*~1~*,ε*~2~*) over *k*(*k*=1, 2, ..., *K*), where *Q*(*k*;ε*~1~*,ε*~2~*) denotes the value of *Q*(ε*~1~*,ε*~2~*) corresponding to the *k^th^* prognostic factor. As an alternative, an empirical test analogous to the permutation test presented in the "maximally selected rank statistics" section would be applied to the CR data with multiple prognostic factors.
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![Box plot of tumor size with the five numbers.](ymj-60-517-g001){#F1}

![Empirical *p* values of the proposed test *Q*(ε*~1~*,ε*~2~*) calculated from a simulated sample against the number of permutation times *b* for four combinations of α and *p* under H~0~:β=0 when ε*~1~*=0.1 and ε*~2~*=0.9: solid line for n=50, dashed line for n=100, dotted line for n=200, and the long-dashed vertical line at the 250th permutation time.](ymj-60-517-g002){#F2}

![Empirical distribution function (CDF) of the cutpoint estimator μ̂ for the combinations of α and *p* when n=100: the solid line for β=0, the dashed line for β=1, the dotted line for β=1.5, the dotted and dashed line for β=2, and the long-dashed line for β=3. CDF, cumulative distribution function.](ymj-60-517-g003){#F3}

![Plot of standardized linear rank statistic and cumulative incidence function (CIFs) of two groups classified depending on the estimated cutpoint. Left panel: standardized linear rank statistic *T~µ~* against tumor size (solid line), estimated cutpoint (dashed line), and the 1st, 10th, 90th, and 99th quantile points of tumor size of each sub-sample (black square, black circle, black triangle, and black diamond in order). Right panel: CIF for the event time of interest of two groups, ≤ and \> μ̂.](ymj-60-517-g004){#F4}

###### Summary Statistics of Time to Event Occurrence and Tumor Size Depending on the Event Type
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  Event type   Frequency   Tumor size (cm)   Time (months) to event occurrence                                         
  ------------ ----------- ----------------- ----------------------------------- ------- ------ ------- ------- ------ ------
  Censoring    113         1.78              1.60                                1.287   1.50   125.4   126.0   38.4   66.0
  Relapse      580         3.65              3.25                                2.120   2.00   25.1    16.4    25.2   25.6
  Death        65          2.37              2.10                                1.423   1.60   48.4    38.0    39.2   36.0

SD, standard deviation; IQR, interquartile range.

###### The Proportion of CR, BIAS, and SD of the Cutpoint Estimator μ̂ and the A.Pow and P.Pow Power of the Proposed Test Statistic *Q*(ε*~1~*,ε*~2~*) for Each Combination α of *p* and When n=50, 100, and 200
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  α            β        CR       n=50     n=100   n=200                                                                         
  ----- ------ -------- -------- -------- ------- -------- -------- -------- ------- -------- -------- -------- ------- ------- -------
  0     0      0        0.50     −0.023   0.26    0.018    0.062    0.003    0.27    0.038    0.054    −0.008   0.27    0.058   0.076
  1     0.38   −0.006   0.17     0.352    0.480   −0.007   0.13     0.660    0.738   −0.002   0.09     0.948    0.956           
  1.5   0.34   −0.024   0.12     0.782    0.854   −0.011   0.06     0.984    0.988   −0.004   0.03     1        1               
  2     0.30   −0.022   0.06     0.976    0.986   −0.012   0.03     1        1       −0.006   0.02     1        1               
  3     0.27   −0.032   0.05     1        1       −0.013   0.02     1        1       −0.006   0.01     1        1               
  0.3   0      0.35     0.002    0.27     0.020   0.054    −0.003   0.27     0.030   0.040    −0.002   0.28     0.030   0.050   
  1     0.26   0.020    0.17     0.312    0.438   −0.007   0.13     0.602    0.704   0.005    0.08     0.938    0.960           
  1.5   0.22   −0.007   0.12     0.638    0.746   −0.006   0.07     0.954    0.972   −0.001   0.04     1        1               
  2     0.19   −0.013   0.07     0.934    0.968   −0.009   0.04     1        1       −0.003   0.02     1        1               
  3     0.14   −0.019   0.04     0.998    1       −0.011   0.02     1        1       −0.005   0.01     1        1               
  0.3   0      0        0.50     −0.016   0.27    0.018    0.046    −0.017   0.27    0.032    0.062    0.001    0.27    0.030   0.042
  1     0.38   −0.009   0.18     0.316    0.456   0.012    0.12     0.672    0.728   0.002    0.08     0.928    0.944           
  1.5   0.33   −0.029   0.11     0.784    0.860   −0.012   0.06     0.982    0.986   −0.004   0.04     1        1               
  2     0.30   −0.026   0.05     0.970    0.990   −0.011   0.03     1        1       −0.006   0.02     1        1               
  3     0.27   −0.026   0.03     1        1       −0.014   0.02     1        1       −0.006   0.01     1        1               
  0.3   0      0.35     −0.010   0.27     0.024   0.032    −0.011   0.27     0.032   0.040    −0.019   0.28     0.032   0.054   
  1     0.26   0.008    0.18     0.254    0.400   0.014    0.14     0.596    0.646   0.003    0.08     0.930    0.954           
  1.5   0.21   −0.012   0.12     0.702    0.790   −0.007   0.08     0.942    0.956   −0.005   0.04     1        1               
  2     0.19   −0.021   0.08     0.934    0.966   −0.008   0.04     1        1       −0.003   0.02     1        1               
  3     0.14   −0.020   0.04     1        1       −0.010   0.02     1        1       −0.005   0.01     1        1               

CR, competing risk; BIAS, bias; SD, standard deviation; A.Pow, approximated power; P.Pow, permutation-based power.

###### Split Criterion of the Covariate Size, the Number of Patients of Each Node, the Estimated Cutpoint μ̂, the Proposed Test Statistic *Q*(ε*~1~*,ε*~2~*), and Approximated and Permutation-Based *p* values
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  Split         n     CR     Censoring   μ̂     *Q*(*є~1~,є~2~*)   *p* value   
  ------------- ----- ------ ----------- ----- ------------------ ----------- ---------
                758   0.09   0.10        1.8   10.66              \<0.001     \<0.001
  Size ≤1.8     164   0.15   0.43        1.4   2.39               0.238       0.096
  Size \>;1.8   594   0.07   0.07        3     5.19               \<0.001     \<0.001
  Size ≤3       260   0.10   0.12        2.7   0.77               0.854       0.894
  Size \>;3     334   0.04   0.04        6.5   3.00               0.057       0.020
  Size ≤6.5     292   0.05   0.04        5.5   1.55               0.790       0.530
  Size \>;6.5   42    0      0.02        7     0.75               0.835       0.957

CR, competing risk.
